11/06/2025 | Press release | Distributed by Public on 11/06/2025 16:02
Management's Discussion and Analysis of Financial Condition and Results of Operations
The following Management's Discussion and Analysis of Financial Condition and Results of Operations describes the principal factors affecting the results of operations, financial condition, and changes in financial condition for the three and nine months ended September 30, 2025. This discussion should be read in conjunction with the accompanying Condensed Consolidated Financial Statements, and the notes thereto set forth in Part I, Item 1 of this Quarterly Report on Form 10-Q and our December 31, 2024 Audited Consolidated Financial Statements and notes thereto included in our Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission ("SEC") on March 12, 2025.
Overview
Westrock Coffee Company, a Delaware corporation (the "Company," "Westrock," "we," "us," or "our"), is a leading integrated coffee, tea, flavors, extracts, and ingredients solutions provider in the United States, providing coffee sourcing, supply chain management, product development, roasting, packaging, and distribution services to the retail, food service and restaurant, convenience store and travel center, non-commercial account, CPG, and hospitality industries around the world.
Our platform is built upon four fundamental pillars that enable us to positively impact the coffee, tea, flavors, extracts, and ingredients ecosystems from crop to cup: (i) we operate a transparent supply chain, (ii) we develop innovative beverage solutions tailored to our customers' specific needs, (iii) we deliver a high quality and comprehensive set of products to our customers, and (iv) we leverage our scaled international presence to serve our blue-chip customer base. These four tenets comprise the backbone of our platform and position us as a leading provider of value-added beverage solutions. By partnering with Westrock, our customers also benefit from the benchmark-setting responsible sourcing policies and strong Environmental, Social, and Governance focus surrounding our products, top tier consumer insights, and a differentiated product ideation process. Leading brands choose us because we are singularly positioned to meet their needs, while simultaneously driving a new standard for sustainably and responsibly sourced products.
We operate our business in two segments: Beverage Solutions and Sustainable Sourcing & Traceability ("SS&T").
Beverage Solutions: Through this segment, we combine our product innovation and customer insights to provide value-added beverage solutions, including coffee, tea, flavors, extracts, and ingredients. We provide products in a variety of packaging, including branded and private label coffee in bags, fractional packs, single serve cups, multi-serve bottles and ready-to-drink bottles and cans, as well as extract solutions to be used in products such as cold brew and ready-to-drink offerings. Currently, we serve customers in the United States, Europe, and Asia through the retail, food service and restaurant, convenience store and travel center, non-commercial account, CPG and hospitality industries.
Sustainable Sourcing & Traceability: Through this segment, we utilize our proprietary technology and digitally traceable supply chain to directly impact and improve the lives of our farming partners, provide tangible economic empowerment and emphasize environmental accountability and farmer literacy. Revenues primarily consist of sales from commodity contracts related to forward sales of green coffee.
Significant Developments
Equity Method Investment and De-Consolidation of Rwanda Trading Company
On April 1, 2025, the Company entered into an agreement with ETC Holdings SA ("ECOM") that combines Westrock's and ECOM's Rwandan export operations (the "Rwandan JV"). This strategic partnership, which was established to trade Arabica coffee from Rwanda and commercially operate wet mill and storage facilities, allows Westrock to scale its operations in Rwanda, improve profitability, and strengthen our ability to provide smallholder farmers and their families the ability to advance their quality of life and economic well-being. The Company contributed its ownership interest in Rwanda Trading Company ("RTC") and $100,000 in cash in exchange for a 49.9% ownership interest in the Rwandan JV. As a result of the transaction, the Company de-consolidated RTC, de-recognizing $9.3 million of assets, including approximately $2.9 million of cash and cash equivalents, and $10.3 million of liabilities that were previously reported
within our Sustainable Sourcing & Traceability segment. Upon de-consolidation, the Company recognized a $2.3 million gain, which is recorded in other, net on the Condensed Consolidated Statements of Operations.
Falcon Credit Agreement Amendment
On July 23, 2025, Falcon Coffees Limited ("Falcon") amended its working capital trade finance facility with multiple institutions. The facility size was increased from $85.0 million to $102.5million and remains uncommitted and repayable on demand, with certain of Falcon's assets pledged as collateral against the facility.
Convertible Notes Offering and Credit Agreement Amendment
On November 4, 2025, the Company sold and issued in a private placement $30.0 million in aggregate principal amount of 5.00% convertible senior notes due 2031 (the "2031 Convertible Notes"). The 2031 Convertible Notes will be unsecured and senior obligations of the Company and will accrue interest at a rate of 5.00% per annum. The purchasers of the 2031 Convertible Notes include, among others, HF Direct Investments Pool, LLC (a holder of more than 10% of the outstanding Common Stock), Jeffrey H. Fox Revocable Trust (an affiliate of Jeffrey H. Fox, a member of the board of directors of the Company), and an affiliate of The Stephens Group, LLC (a holder of more than 5% of the outstanding Common Stock).
On November 4, 2025, the Company entered into Amendment No. 5 (the "Fifth Amendment") to the Credit Agreement (as defined below). The Fifth Amendment modified the existing Covenant Relief Period (as defined below), which commenced on June 30, 2023, and will end on the earlier to occur of (i) October 1, 2026 and (ii) any date following June 30, 2024, on which the Borrower (as defined below) elects to terminate the Covenant Relief Period subject to satisfaction of certain conditions.
For additional information on the 2031 Convertible Notes and Fifth Amendment, see Note 21, "Subsequent Events" to the Condensed Consolidated Financial Statements included in Item I of Part 1 of this Quarterly Report on Form 10-Q and the section below titled "Liquidity and Capital Resources."
Results of Operations
Comparison of the Three Months Ended September 30, 2025 and 2024
The following table sets forth our results of operations expressed as dollars and as a percentage of total revenues for the periods indicated:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months |
|
|
|
|
Three Months |
|
|
|
|
||
|
|
Ended |
% of |
|
Ended |
% of |
|
|||||||
|
(Dollars in Thousands) |
|
September 30, 2025 |
|
Revenues |
|
September 30, 2024 |
|
Revenues |
|
||||
|
Net sales |
|
$ |
354,825 |
|
100.0 |
% |
|
$ |
220,860 |
|
100.0 |
% |
|
|
Costs of sales |
|
313,423 |
88.3 |
% |
|
183,775 |
83.2 |
% |
|
||||
|
Gross profit |
|
41,402 |
11.7 |
% |
|
37,085 |
16.8 |
% |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative expense |
|
46,996 |
13.2 |
% |
|
46,132 |
20.9 |
% |
|
||||
|
Transaction, restructuring and integration expense |
|
3,029 |
0.9 |
% |
|
2,538 |
1.1 |
% |
|
||||
|
Impairment charges |
|
|
- |
0.0 |
% |
|
1,165 |
0.5 |
% |
|
|||
|
Loss (gain) on disposal of property, plant and equipment |
|
8 |
0.0 |
% |
|
(8) |
(0.0) |
% |
|
||||
|
Total operating expenses |
|
50,033 |
14.1 |
% |
|
49,827 |
22.6 |
% |
|
||||
|
Loss from operations |
|
(8,631) |
(2.4) |
% |
|
(12,742) |
(5.8) |
% |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other (income) expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense |
|
|
14,023 |
|
4.0 |
% |
|
|
6,889 |
|
3.1 |
% |
|
|
Change in fair value of warrant liabilities |
|
- |
0.0 |
% |
|
(5,481) |
(2.5) |
% |
|
||||
|
Other, net |
|
(992) |
(0.3) |
% |
|
(10) |
(0.0) |
% |
|
||||
|
Loss before income taxes and equity in earnings from unconsolidated entities |
|
(21,662) |
(6.1) |
% |
|
(14,140) |
(6.4) |
% |
|
||||
|
Income tax expense (benefit) |
|
(122) |
(0.0) |
% |
|
84 |
0.0 |
% |
|
||||
|
Equity in (earnings) loss from unconsolidated entities |
|
(2,437) |
|
(0.7) |
% |
|
35 |
0.0 |
% |
|
|||
|
Net loss |
|
$ |
(19,103) |
(5.4) |
% |
|
$ |
(14,259) |
(6.5) |
% |
|
||
|
Amortization of Series A Convertible Preferred Shares |
|
|
88 |
|
0.0 |
% |
|
|
88 |
|
0.0 |
% |
|
|
Net loss attributable to common shareholders |
|
$ |
(19,015) |
(5.4) |
% |
|
$ |
(14,171) |
(6.4) |
% |
|
||
Net Sales
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
||||
|
(Thousands) |
2025 |
2024 |
||||
|
Beverage Solutions |
|
$ |
263,029 |
|
$ |
164,010 |
|
Sustainable Sourcing & Traceability(1) |
|
91,796 |
|
56,850 |
||
|
Total net sales |
|
$ |
354,825 |
|
$ |
220,860 |
| (1) | Net of intersegment revenues. |
Net Sales from our Beverage Solutions segment were $263.0 million for the three months ended September 30, 2025, increasing 60.4% compared to $164.0 million for the three months ended September 30, 2024. The increase was primarily due to a $70.9 million increase in the sale of coffee and tea products, driven by an 84.8% increase in single serve cup volumes and a 4.1% increase in core roast and ground coffee volumes, and the year over year growth in coffee commodity prices and the impact of tariffs, which are both passed through to our customers. In addition, sales of flavors, extracts & ingredients products increased $28.5 million, driven by a 59.6% increase in multi-serve bottle volumes and the ramp up in can production at our Conway, Arkansas extract and ready-to-drink manufacturing facility (the "Conway Facility"). The Company notes that single serve volumes have increased during 2025 in part due to the onboarding of a new customer. This customer is currently involved in a pending transaction in which it would be acquired by a competitor of ours within the coffee industry, which has created uncertainty around this customer's near-term single serve cup commitments. As a result, there can be no assurances that single serve cup volumes reported during the three months ended September 30, 2025 will be achieved in future quarters, which could negatively impact net sales from our Beverage Solutions segment.
Net Sales from our SS&T segment, net of intersegment revenues, were $91.8 million for the three months ended September 30, 2025, increasing 61.5% compared to $56.9 million for the three months ended September 30, 2024. The increase is driven by an increase in the average sales price per pound, which increased 43.1% for the three months ended September 30, 2025, compared to the three months ended September 30, 2024. The increase in the average sales price per pound is directly correlated to the global commodities price. SS&T sales volume increased 15.3% for the three months ended September 30, 2025 compared to the three months ended September 30, 2024.
Costs of Sales
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
||||
|
(Thousands) |
2025 |
2024 |
||||
|
Beverage Solutions |
|
$ |
225,812 |
|
$ |
131,762 |
|
Sustainable Sourcing & Traceability |
|
87,611 |
|
52,013 |
||
|
Total costs of sales |
|
$ |
313,423 |
|
$ |
183,775 |
In our Beverage Solutions segment, costs of sales increased $94.1 million to $225.8 million for the three months ended September 30, 2025, compared to the three months ended September 30, 2024. The increase in costs of sales was primarily driven by an increase in sales volumes and the year over year growth in coffee commodity prices and tariffs for the three months ended September 30, 2025, compared to the three months ended September 30, 2024.
In our SS&T segment, costs of sales increased $35.6 million to $87.6 million for the three months ended September 30, 2025, compared to the three months ended September 30, 2024. This increase is primarily due to an increase in green coffee costs driven by an increase in underlying commodities pricings. Costs of sales in our SS&T segment for the three months ended September 30, 2025 included $2.5 million of net unrealized losses on forward sales and purchase contracts and mark-to-market adjustments on green coffee inventory compared to $0.5 million of net unrealized losses for the three months ended September 30, 2024.
Selling, General and Administrative Expense
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
|
|||||||||
|
|
|
2025 |
|
2024 |
|
|||||||
|
|
|
|
% of Segment |
|
|
% of Segment |
|
|||||
|
(Dollars in Thousands) |
|
Amount |
|
Revenues |
|
Amount |
|
Revenues |
|
|||
|
Beverage Solutions |
|
$ |
44,145 |
16.8 |
% |
$ |
43,126 |
26.3 |
% |
|
||
|
Sustainable Sourcing & Traceability |
|
2,851 |
3.1 |
% |
3,006 |
5.3 |
% |
|
||||
|
Total selling, general and administrative expense |
|
$ |
46,996 |
13.2 |
% |
$ |
46,132 |
20.9 |
% |
|
||
Total selling, general and administrative expenses in our Beverage Solutions segment increased $1.0 million to $44.1 million for the three months ended September 30, 2025, compared to the three months ended September 30, 2024. The increase is primarily due to a $5.4 million increase in employee related costs, which include short-term cash incentive compensation, partially offset by a $2.6 million decrease in start-up costs related to our Conway Facility, and a $1.0 million decrease in service expenses. In our SS&T segment, selling, general and administrative costs were relatively unchanged compared to the three months ended September 30, 2024.
Transaction, Restructuring and Integration Expense
Transaction, restructuring and integration expenses for the three months ended September 30, 2025 were $3.0 million, approximately $2.3 million of which related to severance. During the three months ended September 30, 2024, we incurred $2.5 million of transaction, restructuring and integration expenses, approximately $1.4 million of which related to professional and legal costs associated with the Westrock warrant exchange.
Interest Expense
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
|
||||
|
(Thousands) |
2025 |
2024 |
|
||||
|
Interest expense |
|
|
|
||||
|
Cash: |
|
|
|
||||
|
Term loan and delayed draw term loan facilities |
|
$ |
4,156 |
|
$ |
4,782 |
|
|
Revolving credit facility |
|
|
3,762 |
|
|
2,036 |
|
|
Convertible notes payable |
|
|
281 |
|
|
281 |
|
|
Convertible notes payable - related party |
|
|
639 |
|
|
639 |
|
|
Supply chain finance program |
|
|
1,746 |
|
|
326 |
|
|
International trade finance lines |
|
1,845 |
|
1,596 |
|
||
|
International notes payable |
|
170 |
|
213 |
|
||
|
Other |
|
641 |
|
269 |
|
||
|
Total cash interest |
|
13,240 |
|
10,142 |
|
||
|
Non-cash: |
|
|
|
||||
|
Amortization of deferred financing costs |
|
989 |
|
717 |
|
||
|
Capitalized interest |
|
|
(206) |
|
|
(3,970) |
|
|
Total non-cash interest |
|
783 |
|
(3,253) |
|
||
|
Total interest expense |
|
$ |
14,023 |
|
$ |
6,889 |
|
Interest expense for the three months ended September 30, 2025 was $14.0 million compared to $6.9 million for the three months ended September 30, 2024. Interest expense associated with our term loan and delayed draw term loan decreased $0.6 million due to decreased outstanding balances, while interest on our revolving credit facility increased $1.7 million, primarily due to higher outstanding borrowings. During the three months ended September 30, 2025, the Company capitalized approximately $0.2 million of interest costs associated with the build-out of our Conway Facility, compared to $4.0 million of such interest costs for the three months ended September 30, 2024.
Income Tax Expense (Benefit)
Income tax benefit for the three months ended September 30, 2025 was $0.1 million, resulting in an effective tax rate of 0.6%. The effective tax rate for the current period differs from the federal statutory rate primarily due to an increase in the valuation allowance against domestic deferred tax assets. Income tax expense for the three months ended September 30, 2024 was $0.1 million, resulting in an effective tax rate of (0.6)%.
Comparison of the Nine Months Ended September 30, 2025 and 2024
The following table sets forth our results of operations expressed as dollars and as a percentage of total revenues for the periods indicated:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended |
% of |
|
Nine Months Ended |
% of |
|||||||
|
(Dollars in Thousands) |
|
September 30, 2025 |
|
Revenues |
|
September 30, 2024 |
|
Revenues |
||||
|
Net Sales |
|
$ |
849,480 |
|
100.0 |
% |
|
$ |
621,749 |
|
100.0 |
% |
|
Costs of sales |
|
737,610 |
86.8 |
% |
|
505,987 |
81.4 |
% |
||||
|
Gross profit |
|
111,870 |
13.2 |
% |
|
115,762 |
18.6 |
% |
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative expense |
|
141,271 |
16.6 |
% |
|
142,182 |
22.9 |
% |
||||
|
Transaction, restructuring and integration expense |
|
7,297 |
0.9 |
% |
|
9,901 |
1.6 |
% |
||||
|
Impairment charges |
|
|
- |
0.0 |
% |
|
1,996 |
0.3 |
% |
|||
|
Loss on disposal of property, plant and equipment |
|
15 |
0.0 |
% |
|
965 |
0.2 |
% |
||||
|
Total operating expenses |
|
148,583 |
17.5 |
% |
|
155,044 |
24.9 |
% |
||||
|
Loss from operations |
|
(36,713) |
(4.3) |
% |
|
(39,282) |
(6.3) |
% |
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other (income) expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense |
|
|
39,741 |
|
4.7 |
% |
|
|
21,921 |
|
3.5 |
% |
|
Change in fair value of warrant liabilities |
|
- |
0.0 |
% |
|
(7,134) |
(1.1) |
% |
||||
|
Other, net |
|
(3,962) |
(0.5) |
% |
|
223 |
0.0 |
% |
||||
|
Loss before income taxes and equity in earnings from unconsolidated entities |
|
(72,492) |
(8.5) |
% |
|
(54,292) |
(8.7) |
% |
||||
|
Income tax expense (benefit) |
|
1,336 |
0.2 |
% |
|
1,254 |
0.2 |
% |
||||
|
Equity in (earnings) loss from unconsolidated entities |
|
|
(5,944) |
(0.7) |
% |
|
145 |
0.0 |
% |
|||
|
Net loss |
|
$ |
(67,884) |
(8.0) |
% |
|
$ |
(55,691) |
(9.0) |
% |
||
|
Amortization of Series A Convertible Preferred Shares |
|
|
260 |
|
0.0 |
% |
|
|
262 |
|
0.0 |
% |
|
Net loss attributable to common shareholders |
|
$ |
(67,624) |
(8.0) |
% |
|
$ |
(55,429) |
(8.9) |
% |
||
Net Sales
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended September 30, |
||||
|
(Thousands) |
2025 |
2024 |
||||
|
Beverage Solutions |
|
$ |
635,922 |
|
$ |
485,322 |
|
Sustainable Sourcing & Traceability(1) |
|
213,558 |
|
136,427 |
||
|
Total net sales |
|
$ |
849,480 |
|
$ |
621,749 |
| (1) | Net of intersegment revenues. |
Net Sales from our Beverage Solutions segment were $635.9 million for the nine months ended September 30, 2025, increasing 31.0% compared to $485.3 million for the nine months ended September 30, 2024. The increase was primarily due to a $111.7 million increase in the sale of coffee and tea products, driven by a 17.5% increase in single serve cup volumes, an 8.4% increase in core roast and ground coffee volumes and the year over year growth in coffee commodity prices and tariffs, both of which are passed through to our customers. In addition, sales of flavors, extracts
& ingredients products increased $39.9 million, driven by the ramp up in operations of the Conway Facility. The Company notes that single serve volumes have increased during 2025 in part due to the onboarding of a new customer. This customer is currently involved in a pending transaction in which it would be acquired by a competitor of ours within the coffee industry, which has created uncertainty around this customer's near-term single serve cup commitments. As a result, there can be no assurances that single serve cup volumes reported during the nine months ended September 30, 2025 will be achieved in future quarters, which could negatively impact net sales from our Beverage Solutions segment.
Net Sales from our SS&T segment, net of intersegment revenues, were $213.6 million for the nine months ended September 30, 2025, increasing 56.5% compared to $136.4 million for the nine months ended September 30, 2024. The increase is primarily driven by an increase in the average sales price per pound, which increased 44.4% for the nine months ended September 30, 2025, compared to the nine months ended September 30, 2024. The increase in the average sales price per pound is directly correlated to the global commodities price.
Costs of Sales
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended September 30, |
||||
|
(Thousands) |
2025 |
2024 |
||||
|
Beverage Solutions |
|
$ |
541,710 |
|
$ |
383,460 |
|
Sustainable Sourcing & Traceability |
|
195,900 |
|
122,527 |
||
|
Total costs of sales |
|
$ |
737,610 |
|
$ |
505,987 |
In our Beverage Solutions segment, costs of sales increased to $541.7 million for the nine months ended September 30, 2025, from $383.5 million for the nine months ended September 30, 2024. The increase in costs of sales was primarily driven by an increase in the sales volumes, and the year over year growth in coffee commodity prices and tariffs for the nine months ended September 30, 2025 compared to the nine months ended September 30, 2024.
In our SS&T segment, costs of sales increased $73.4 million to $195.9 million for the nine months ended September 30, 2025 compared to the nine months ended September 30, 2024. This increase is primarily due to an increase in coffee commodity prices. Costs of sales in our SS&T segment for the nine months ended September 30, 2025 included $1.0 million of net unrealized gains on forward sales and purchase contracts and mark-to-market adjustments on green coffee inventory compared to $2.7 million of net unrealized gains for the nine months ended September 30, 2024.
Selling, General and Administrative Expense
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended September 30, |
|||||||||
|
|
|
2025 |
|
2024 |
|||||||
|
|
|
|
% of Segment |
|
|
% of Segment |
|||||
|
(Dollars in Thousands) |
|
Amount |
|
Revenues |
|
Amount |
|
Revenues |
|||
|
Beverage Solutions |
|
$ |
133,429 |
21.0 |
% |
$ |
133,920 |
27.6 |
% |
||
|
Sustainable Sourcing & Traceability |
|
7,842 |
3.7 |
% |
8,262 |
6.1 |
% |
||||
|
Total selling, general and administrative expense |
|
$ |
141,271 |
16.6 |
% |
$ |
142,182 |
22.9 |
% |
||
Total selling, general and administrative expenses in our Beverage Solutions segment and our SS&T segment were relatively unchanged compared to the nine months ended September 30, 2024.
Transaction, Restructuring and Integration Expense
Transaction, restructuring and integration expenses for the nine months ended September 30, 2025 were $7.3 million, approximately $5.0 million of which related to severance and other employee termination and benefit costs associated with the elimination of various positions as part of cost reduction objectives, $0.8 million of plant closure costs and $0.3 million of which related to fees related to the establishment of our accounts receivable factoring agreement. During the nine months ended September 30, 2024, we incurred $9.9 million of transaction, restructuring and integration expenses, approximately $3.5 million of which related to severance and other employee termination and benefit costs associated with the elimination of various positions as part of cost reduction objectives, $2.4 million of which related to the establishment of our at-the-market common stock offering program and $1.4 million of which related to professional and legal costs associated with the Westrock warrant exchange.
Interest Expense
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended September 30, |
||||
|
(Thousands) |
2025 |
2024 |
||||
|
Interest expense |
|
|
||||
|
Cash: |
|
|
||||
|
Term loan and delayed draw term loan facilities |
|
$ |
11,965 |
|
$ |
14,312 |
|
Revolving credit facility |
|
|
10,879 |
|
|
3,863 |
|
Convertible notes payable |
|
|
834 |
|
|
697 |
|
Convertible notes payable - related party |
|
|
1,896 |
|
|
1,583 |
|
Supply chain finance program |
|
|
5,801 |
|
|
4,870 |
|
International trade finance lines |
|
4,601 |
|
3,604 |
||
|
International notes payable |
|
515 |
|
611 |
||
|
Other |
|
1,206 |
|
1,082 |
||
|
Total cash interest |
|
37,697 |
|
30,622 |
||
|
Non-cash: |
|
|
||||
|
Amortization of deferred financing costs |
|
2,881 |
|
2,432 |
||
|
Capitalized interest |
|
|
(837) |
|
|
(11,133) |
|
Total non-cash interest |
|
2,044 |
|
(8,701) |
||
|
Total interest expense |
|
$ |
39,741 |
|
$ |
21,921 |
Interest expense for the nine months ended September 30, 2025 was $39.7 million compared to $21.9 million for the nine months ended September 30, 2024. Interest expense associated with our term loan and delayed draw term loan facilities decreased $2.3 million due to a decrease in outstanding balances, while interest on our revolving credit facility increased $7.0 million, primarily due to higher outstanding borrowings. During the nine months ended September 30, 2025, the Company capitalized approximately $0.8 million of interest costs associated with the build-out of our Conway Facility, compared to $11.1 million of such interest costs for the nine months ended September 30, 2024.
Income Tax Expense (Benefit)
Income tax expense for the nine months ended September 30, 2025 was $1.3 million, resulting in an effective tax rate of (2.0)%. The effective tax rate for the current period differs from the federal statutory rate primarily due to an increase in the valuation allowance against domestic deferred tax assets. Income tax expense for the nine months ended September 30, 2024 was $1.3 million, resulting in an effective tax rate of (2.3)%.
Critical Accounting Estimates
We make certain judgments and use certain estimates and assumptions when applying accounting principles in the preparation of our financial statements. The nature of those estimates and assumptions are material due to the levels of subjectivity and judgment necessary to account for highly uncertain factors or the susceptibility of such factors to change.
We believe the current assumptions and other considerations used to estimate amounts reflected in our financial statements are appropriate. However, if actual experience differs from the assumptions and other considerations used in estimating amounts reflected in our financial statements, the resulting changes could have a material adverse effect on our results of operations and, in certain situations, could have a material adverse effect on our financial condition.
For further information on our critical accounting estimates, see "Management's Discussion and Analysis of Financial Condition and Results of Operations" and the notes to our audited financial statements included in our Annual Report on Form 10-K filed with the SEC on March 12, 2025. As of September 30, 2025, there have been no material changes to these estimates.
Key Business Metrics
We use Consolidated Adjusted EBITDA to evaluate our performance, identify trends, formulate financial projections, and to make strategic decisions.
Consolidated Adjusted EBITDA
We refer to EBITDA and Consolidated Adjusted EBITDA in our analysis of our results of operations, which are not required by, or presented in accordance with, accounting principles generally accepted in the United States ("GAAP"). While we believe that net (loss) income, as defined by GAAP, is the most appropriate earnings measure, we also believe that EBITDA and Consolidated Adjusted EBITDA are important non-GAAP supplemental measures of operating performance as they contribute to a meaningful evaluation of the Company's future operating performance and comparisons to the Company's past operating performance. The Company believes that providing these non-GAAP financial measures helps investors evaluate the Company's operating performance, profitability and business trends in a way that is consistent with how management evaluates such performance.
We define "EBITDA" as net (loss) income, as defined by GAAP, before interest expense, provision for income taxes and depreciation and amortization. We define "Consolidated Adjusted EBITDA" as EBITDA before equity-based compensation expense and the impact, which may be recurring in nature, of transaction, restructuring and integration related costs, impairment charges, changes in the fair value of warrant liabilities, non-cash mark-to-market adjustments, certain non-capitalizable costs necessary to place the Conway Facility into commercial production, the write off of unamortized deferred financing costs, costs incurred as a result of the early repayment of debt, gains or losses on dispositions, and other similar or infrequent items (although we may not have had such charges in the periods presented). We believe EBITDA and Consolidated Adjusted EBITDA are important supplemental measures to net (loss) income because they provide additional information to evaluate our operating performance on an unleveraged basis.
Since EBITDA and Consolidated Adjusted EBITDA are not measures calculated in accordance with GAAP, they should be viewed in addition to, and not be considered as alternatives for, net (loss) income determined in accordance with GAAP. Further, our computations of EBITDA and Consolidated Adjusted EBITDA may not be comparable to that reported by other companies that define EBITDA and Consolidated Adjusted EBITDA differently than we do.
The reconciliation of our net (loss) income to EBITDA and Consolidated Adjusted EBITDA for the three and nine months ended September 30, 2025 and 2024 is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
Nine Months Ended September 30, |
|
|||||||||
|
(Thousands) |
2025 |
2024 |
2025 |
2024 |
|
||||||||
|
Net loss |
|
$ |
(19,103) |
|
$ |
(14,259) |
|
$ |
(67,884) |
|
$ |
(55,691) |
|
|
Interest expense |
|
14,023 |
|
6,889 |
|
39,741 |
|
21,921 |
|
||||
|
Income tax expense (benefit) |
|
(122) |
|
84 |
|
1,336 |
|
1,254 |
|
||||
|
Depreciation and amortization |
|
13,898 |
|
7,680 |
|
40,669 |
|
23,196 |
|
||||
|
EBITDA |
|
8,696 |
|
394 |
|
13,862 |
|
(9,320) |
|
||||
|
Transaction, restructuring and integration expense |
|
3,029 |
|
2,538 |
|
7,297 |
|
9,901 |
|
||||
|
Change in fair value of warrant liabilities |
|
|
- |
|
|
(5,481) |
|
|
- |
|
|
(7,134) |
|
|
Equity-based compensation |
|
3,629 |
|
3,028 |
|
11,709 |
|
8,508 |
|
||||
|
Impairment charges |
|
|
- |
|
|
1,165 |
|
|
- |
|
|
1,996 |
|
|
Conway extract and ready-to-drink facility pre-production costs |
|
|
5,246 |
|
|
7,937 |
|
|
18,766 |
|
|
30,115 |
|
|
Mark-to-market adjustments |
|
2,531 |
|
470 |
|
(983) |
|
(2,692) |
|
||||
|
Loss (gain) on disposal of property, plant and equipment |
|
8 |
|
(8) |
|
15 |
|
965 |
|
||||
|
Other |
|
20 |
|
226 |
|
(3,946) |
|
1,506 |
|
||||
|
Consolidated Adjusted EBITDA |
|
$ |
23,159 |
|
$ |
10,269 |
|
$ |
46,720 |
|
$ |
33,845 |
|
Liquidity and Capital Resources
Our principal liquidity needs are to fund operating expenses, meet debt service obligations, and fund investment activities, which include capital expenditures. Our primary sources of liquidity and capital resources are cash on hand, cash provided by operating activities, and available borrowings under our Credit Agreement (as defined herein).
Our ability to generate cash provided by operating activities is dependent on several factors, including our ability to generate net sales and manage costs in line with our expectations. Failure to meet our financial targets, including any adverse impact from changes or further delays in the estimated timing and volume of products to be commercialized in our Conway Facility, may restrict our liquidity and capital resources and our ability to maintain compliance with our financial covenants and may require us to modify, delay, or abandon some of our planned future expansion or development, or to otherwise enact operating cost reductions, which could have a material adverse effect on our business, operating results, financial condition, covenant compliance and ability to achieve our intended business objectives.
Green coffee, which is our primary raw material, is an exchange traded agricultural commodity that is subject to price fluctuations, the reasons for which are outside of the control of the Company. During the year ended December 31, 2024, the exchange traded "C" market price of green coffee increased approximately 70%, and from January 1, 2025 through the date of this Quarterly Report on Form 10-Q, the "C" market price has continued to fluctuate, at times surpassing $4.00 per pound of green coffee, reaching all-time highs. This increase impacts the entire coffee supply chain, as exporters, traders, suppliers, and roasters require increased working capital to fund rising green coffee costs, and without having access to sufficient working capital, supply chain disruptions may emerge.
In addition, our liquidity may be negatively impacted by recently enacted and/or proposed tariffs and trading restrictions that, absent an exemption, would be applied to imported equipment, commodities and packaging materials. The uncertainty around the long-term tariff rates that could be applied to our importation of products into the U.S. presents significant challenges to our operations and supply chain and may result in future results being significantly different than any outlook given. We cannot predict what additional actions might be considered or implemented by the U.S. or its trade partners, particularly in the current geopolitical environment. The uncertainty could also cause disturbances in ocean shipping capacity that could affect our ability to secure ocean freight containers for our products, and create inflationary effects on our costs, in addition to the direct impact of tariffs. For example, recent tariffs targeting Brazil and other coffee-producing nations are currently impacting our ability and the ability of competitors to source coffee and
have led to increases in the cost of commodities, adversely affecting our profitability. A persistent increase in coffee costs or tariff-impacted equipment or material costs, could adversely affect consumer demand as producers attempt to pass higher costs down the supply chain.
Where possible, we will seek to recover tariff- and inflation-impacted costs by passing these costs onto our customers through periodic pricing increases. However, our pricing increases often lag our cost increases, including increases in commodity costs. A prolonged increase in "C" market prices and/or tariff-impacted costs combined with the near-term costs associated with continuing to build out the remaining portions of the Conway Facility, may require us to evaluate our allocation of working capital, and if we are not able to effectively manage our working capital, or do not have access to sufficient working capital to meet our purchasing needs for green coffee, other commodity inputs, ingredients or supplies (such as materials used in our packaging), we may need to access the debt or equity capital markets, and there is no assurance that we will be able to do so on terms that are favorable to the Company or at all. In addition, we may be required to modify, delay, or abandon some of our planned future expansion or development, or to otherwise enact operating cost reductions, which could have a material adverse effect on our business, operating results, financial condition, covenant compliance and ability to achieve our intended business objectives.
Credit Agreement
The Company is party to a credit agreement (as amended, modified or supplemented, the "Credit Agreement") among the Company, Westrock Beverage Solutions, LLC, as the borrower (the "Borrower"), Wells Fargo Bank, N.A., as administrative agent, collateral agent, and swingline lender, Wells Fargo Securities, LLC, as sustainability structuring agent, and each issuing bank and lender party thereto. The Credit Agreement includes (a) a senior secured first lien revolving credit facility in an aggregate principal amount of $200.0 million (the "Revolving Credit Facility"), (b) a senior secured first lien term loan facility in an aggregate principal amount of $175.0 million (the "Term Loan Facility"), and (c) incremental term loan commitments in the form of a senior secured delayed draw term loan credit facility (the "Delayed Draw Term Loan Facility") in the aggregate principal amount of $50.0 million. The Revolving Credit Facility, the Term Loan Facility and the Delayed Draw Term Loan Facility will mature on August 29, 2027. All obligations under the Credit Agreement are guaranteed by the Company and each of the Borrower's domestic subsidiaries, which comprise our Beverage Solutions segment, and are secured by substantially all of the Company's assets.
Borrowings under the Revolving Credit Facility, the Term Loan Facility and the Delayed Draw Term Loan Facility will bear interest, at the Borrower's option, initially at an annual rate equal to (a) term SOFR plus a credit spread adjustment of 0.10% for loans with an interest period of one month, 0.15% for loans with an interest period of three months and 0.25% for loans with an interest period of six months, as applicable, (the "Adjusted Term SOFR") or (b) the base rate (determined by reference to the greatest of (i) the rate of interest last quoted by The Wall Street Journal in the United States as the prime rate in effect, (ii) the NYFRB Rate from time to time plus 0.50% and (iii) the Adjusted Term SOFR for a one month interest period plus 1.00%, (the "Base Rate")), in each case plus an applicable margin.
At September 30, 2025, we had $182.5 million of outstanding borrowings under the Revolving Credit Facility, with a weighted average interest rate of 8.1% and we had $2.0 million of standby letters of credit outstanding. At September 30, 2025, the interest rate applicable to our Term Loan Facility was 7.9%, and the interest rate applicable to our Delayed Draw Term Loan Facility was 8.2%.
On February 15, 2024, the Borrower entered into Amendment No. 3 (the "Third Amendment") to the Credit Agreement. The Third Amendment modified the existing covenant relief period (the "Covenant Relief Period"), which commenced on June 30, 2023 and will end on the earlier to occur of (i) April 1, 2026 and (ii) any date following June 30, 2024, on which the Borrower elects to terminate the Covenant Relief Period subject to satisfaction of certain conditions. During the Covenant Relief Period, the Company's ability to incur additional indebtedness and make investments, restricted payments and junior debt restricted payments will be more limited. The Third Amendment permits the Company to issue convertible notes, including the Convertible Notes (as defined herein).
During the Covenant Relief Period, the applicable margin for any term SOFR rate loan will range from 3.00% to 4.00% and for any ABR loan will range from 2.00% to 3.00%, in each case depending on the secured net leverage ratio. After the Covenant Relief Period, the applicable margin for any term SOFR rate loan will range from 2.00% to 3.00% and for any ABR loan will range from 1.00% to 2.00%, in each case depending on the secured net leverage ratio.
The Credit Agreement, as amended through the Third Amendment, required the Borrower to maintain compliance with (i) a secured net leverage ratio at levels ranging from 4.50:1.00 to 6.25:1.00 and stepping down to 4.50:1.00 by April 2026 (which has been further amended by the Fourth Amendment, as discussed below) and (ii) an interest coverage ratio of at least 1.50:1.00 on and prior to September 30, 2025 and at least 2.00:1.00 on December 31, 2025 and thereafter. The Credit Agreement, as amended through the Third Amendment, also included (i) a minimum liquidity covenant requiring the Borrower not to permit its liquidity, measured as of the last business day of each calendar month commencing March 29, 2024, to be less than $15.0 million and (ii) an anti-cash hoarding covenant, which shall be effective only during the Covenant Relief Period, requiring the Borrower to have no more than $20.0 million of unrestricted cash on the last day of each calendar month when revolving loans or letters of credit are outstanding or on the date of borrowing of a revolving loan. Failure to comply with these covenants or make payments when due could result in an event of default, which, if not cured or waived, could accelerate our repayment obligations under the Credit Agreement and could result in a default and acceleration under other agreements containing cross-default provisions. Under these circumstances, we might not have sufficient funds or other resources to satisfy all of our obligations.
The Company believes that its secured net leverage under the Credit Agreement is important to the understanding of the Company's financial condition and liquidity. At September 30, 2025, the Company's secured net leverage ratio was 4.58:1.00, compared to a maximum allowable ratio of 5.50:1.00, with such calculation set forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
(Thousands, except leverage ratio) |
Trailing Twelve-Months |
|||
|
Beverage Solutions Segment Adjusted EBITDA |
|
|
$ |
67,517 |
|
Permissible credit agreement adjustments1 |
|
|
|
8,612 |
|
Trailing Twelve-Months Credit Agreement Adjusted EBITDA |
|
|
$ |
76,129 |
|
|
|
|
|
|
|
End of period: |
|
|
|
|
|
Term loan facility |
|
|
$ |
148,750 |
|
Delayed draw term loan facility |
|
|
|
46,250 |
|
Revolving credit facility |
|
|
|
182,500 |
|
Letters of credit outstanding |
|
|
|
1,980 |
|
Secured debt |
|
|
|
379,480 |
|
Beverage Solutions unrestricted cash and cash equivalents |
|
|
|
(31,134) |
|
Secured net debt |
|
|
$ |
348,346 |
|
|
|
|
|
|
|
Beverage Solutions Credit Agreement secured net leverage ratio |
|
|
|
4.58x |
| (1) | - Consists primarily of pro forma run-rate impact of cost savings initiatives, as permitted by the Credit Agreement. |
A reconciliation of trailing twelve-months Beverage Solutions Adjusted EBITDA is as follows:
|
|
|
|
|
|
|
(Thousands) |
|
|
|
|
|
Year ended December 31, 2024 |
|
|
$ |
53,639 |
|
Nine months ended September 30, 2025 |
|
|
|
49,675 |
|
Nine months ended September 30, 2024 |
|
|
|
(35,797) |
|
Trailing Twelve-Months Beverage Solutions Adjusted EBITDA |
|
|
$ |
67,517 |
The Term Loan Facility and Delayed Draw Term Loan Facility require quarterly principal payments totaling approximately $4.2 million (1.875% of the original principal balance), increasing to approximately $5.6 million (2.5% of the original principal balance) during the final year of the agreements.
On January 15, 2025, the Company entered into an Incremental Assumption Agreement and Amendment No. 4 (the "Fourth Amendment") to the Credit Agreement. The Fourth Amendment expanded the syndicate to include member banks from the Farm Credit System and increased the amount of revolving facility commitments (the "Existing Revolving Facility Commitments", and any loans thereunder, the "Existing Revolving Loans") available to the Borrower
under the Credit Agreement by $25.0 million (the "Incremental Revolving Facility Commitments" and any loans thereunder, the "Incremental Revolving Loans"). The amount of revolving facility commitments available to the Borrower under the Credit Agreement, as amended, is $200.0 million. The Incremental Revolving Facility Commitments and the Incremental Revolving Loans are subject to the same interest rates, commitment fees, maturity dates and other terms as the Existing Revolving Facility Commitments and the Existing Revolving Loans.
The Fourth Amendment also modified the secured net leverage ratio that the Company must comply with during the Covenant Relief Period to increase the maximum secured net leverage ratio to (a) 6.00x for the test period ending June 30, 2025, (b) 5.50x for the test period ending September 30, 2025, and (c) 5.25x for the test period ending December 31, 2025. In addition, the minimum liquidity covenant will not apply after the Covenant Relief Period ends. As of the date of this Quarterly Report on Form 10-Q, the Company was in compliance with its financial covenants.
We incurred a total of $1.4 million in financing fees in connection with the Fourth Amendment. The fees were allocated to the Revolving Credit Facility, are reported within other long-term assets on the Condensed Consolidated Balance Sheets and are being amortized ratably over the remaining term of the Revolving Credit Facility.
On November 4, 2025, the Company entered into Amendment No. 5 (the "Fifth Amendment") to the Credit Agreement. The Fifth Amendment modified the existing Covenant Relief Period, which commenced on June 30, 2023, and will end on the earlier to occur of (i) October 1, 2026 and (ii) any date following June 30, 2024, on which the Borrower elects to terminate the Covenant Relief Period subject to satisfaction of certain conditions.
During the Covenant Relief Period, the Borrower's ability to incur additional indebtedness and make investments, restricted payments and junior debt restricted payments is more limited. The Fifth Amendment will permit the Borrower to issue convertible notes, including the 2031 Convertible Notes (as discussed below).
The Fifth Amendment modified the secured net leverage ratio that the Company must comply with during the Covenant Relief Period to increase the maximum secured net leverage ratio to (a) 5.50x for the test period ending December 31, 2025, (b) 5.25x for the test period ending March 31, 2026, (c) 5.00x for the test period ending June 30, 2026, (d) 4.50x for the test period ending September 30, 2026 and (e) 4.00x for the test period ending December 31, 2026. In addition, the Fifth Amendment lowered the interest coverage ratio that the Company must comply with to permit the interest coverage ratio as of the last day of any test period to be less than (a) on and prior to December 31, 2025, 1.50x, (b) on January 1, 2026 and on or prior to September 30, 2026, 1.75x and (z) on October 1, 2026 and thereafter, 2.00x.
Convertible Notes
On February 15, 2024, the Company sold and issued in a private placement $72.0 million in aggregate principal amount of 5.00% convertible senior notes due 2029 (the "Convertible Notes"), of which $50.0 million was from related parties. The Convertible Notes are unsecured, senior obligations of the Company and accrue interest at a rate of 5.00% per annum.
The Convertible Notes are carried at amortized cost and are recorded in long-term debt, net and convertible notes payable - related party, net on the Condensed Consolidated Balance Sheets. At September 30, 2025, the carrying value of the Convertible Notes was $71.7 million, of which $49.8 million was from related parties. We incurred a total of $0.5 million of financing fees in connection with the Convertible Notes, which were ratably allocated to the convertible notes payable and the convertible notes payable - related party, respectively, and are being amortized into interest expense over the remaining term of the Convertible Notes utilizing the effective interest rate method.
Pursuant to the terms of the Convertible Notes, noteholders may convert their Convertible Notes at their option only in the following circumstances: (i) during the period commencing on August 15, 2024, and prior to the close of business on the trading day immediately preceding August 15, 2028, if the closing price for at least 20 trading days (whether or not consecutive) during the period of any 30 consecutive trading days in the immediately preceding calendar quarter is equal to or greater than 130% of the conversion price; (ii) during the period commencing on August 15, 2028, and prior to the close of business on the second scheduled trading day immediately preceding February 15, 2029, at any time; and (iii)
during the 35 trading days following the effective date of certain fundamental change transactions that occur prior to the close of business on the trading day immediately preceding August 15, 2028.
The Company will settle conversions by paying or delivering, as applicable, at the Company's election, cash, common stock, par value $0.01 per share ("Common Shares"), or a combination of cash and Common Shares. The Company may not issue more than 19.99% of the issued and outstanding Common Shares immediately prior to the issuance of the Convertible Notes in respect of the conversion of the Convertible Notes. The initial conversion price of the Convertible Notes is $12.84, which corresponds to an initial conversion rate of approximately 77.88 Common Shares per $1,000 principal amount of Convertible Notes. The conversion price and conversion rate are subject to customary adjustments.
On November 4, 2025, the Company sold and issued in a private placement $30.0 million in aggregate principal amount of 5.00% convertible senior notes due 2031 (the "2031 Convertible Notes"). The 2031 Convertible Notes will be unsecured and senior obligations of the Company and will accrue interest at a rate of 5.00% per annum. Noteholders may convert their 2031 Convertible Notes at their option only in the following circumstances: (A) during the period commencing on May 4, 2026, and prior to the close of business on the trading day immediately preceding August 15, 2030, if the closing price for at least 20 trading days (whether or not consecutive) during the period of any 30 consecutive trading days in the immediately preceding calendar quarter is equal to or greater than 130% of the conversion price; (B) during the period commencing on August 15, 2030, and prior to the close of business on the second scheduled trading day immediately preceding February 15, 2031, at any time; and (C) during the 35 trading days following the effective date of certain fundamental change transactions that occur prior to the close of business on the trading day immediately preceding August 15, 2030.
The Company will settle conversions by paying or delivering, as applicable, at the Company's election, cash, Common Shares or a combination of cash and Common Shares. The initial conversion price of the 2031 Convertible Notes is $5.25, which corresponds to an initial conversion rate of approximately 190.48 Common Shares per $1,000 principal amount of 2031 Convertible Notes. At this initial conversion price, the 2031 Convertible Notes are convertible into approximately 5.7 million Common Shares. The conversion price and conversion rate are subject to customary adjustments, provided that the Company may not issue more than 19.99% of the issued and outstanding Common Shares immediately prior to the issuance of the 2031 Convertible Notes in respect of the conversion of the 2031 Convertible Notes.
The 2031 Convertible Notes do not contain any financial or operating covenants or restrictions on the payments of dividends, the incurrence of indebtedness or the issuance or repurchase of securities by the Company or any of its subsidiaries. The 2031 Convertible Notes contain customary terms regarding events of default. If any event of default (other than certain events of bankruptcy, insolvency or reorganization involving the Company) occurs and is continuing, then each noteholder may, by written notice to the Company, declare the principal amount of, and all accrued and unpaid interest on, such noteholder's 2031 Convertible Notes to become due and payable immediately. If an event of default involving certain events of bankruptcy, insolvency or reorganization occurs, then the principal amount of, and all accrued and unpaid interest on, all of the 2031 Convertible Notes then outstanding will immediately become due and payable without any further action or notice by any person.
International Debt and Lending Facilities
On March 8, 2024, Falcon renewed its working capital trade finance facility with multiple institutions. The facility size was reduced from $70.0 million to $55.0 million and was uncommitted and repayable on demand, with certain of Falcon's assets pledged as collateral against the facility. The facility matured one year from inception. Borrowings under the facility bore interest at the borrower's option at a rate equal to (a) Term SOFR plus a margin of 4.00% plus a liquidity premium set by the lender at the time of borrowing or (b) the Base Rate (determined by reference to the greatest of (i) the Prime Rate, as defined in the facility, at such time, (ii) one-half of 1.00% in excess of the Federal Funds Effective Rate, as defined in the facility, at such time, and (iii) Term SOFR for a one-month tenor in effect at such time plus 1.00%). On August 21, 2024, Falcon amended its working capital trade finance facility, increasing the facility size from $55.0 million to $75.0 million. The interest rates and maturity date were unchanged as a result of the amendment.
On March 7, 2025, Falcon renewed its working capital trade finance facility with multiple institutions. The facility size was increased from $75.0 million to $85.0 million and remains uncommitted and repayable on demand, with certain of Falcon's assets pledged as collateral against the facility. The facility will mature one year from inception. Borrowings under the facility will bear interest at the borrower's option at a rate equal to (a) Term SOFR plus a margin of 4.00% plus a liquidity premium set by the lender at the time of borrowing or (b) the Base Rate (determined by reference to the greatest of (i) the Prime Rate, as defined in the facility, at such time, (ii) one-half of 1.00% in excess of the Federal Funds Effective Rate, as defined in the facility, at such time, and (iii) Term SOFR for a one-month tenor in effect at such time plus 1.00%).
On July 23, 2025, Falcon amended its working capital trade finance facility with multiple institutions. The facility size was increased from $85.0 million to $102.5million and remains uncommitted and repayable on demand, with certain of Falcon's assets pledged as collateral against the facility.
At September 30, 2025, there was $84.1 million of outstanding borrowings under the facility, which is recorded in short-term debt in the Condensed Consolidated Balance Sheets. Falcon's facility contains certain restrictive financial covenants which require Falcon to maintain certain levels of working capital, debt, and net worth. Falcon was in compliance with these financial covenants as of September 30, 2025.
On September 28, 2023, we entered into a $5.0 million unsecured working capital trade finance facility with responsAbility Climate Smart Agriculture & Food Systems Fund through Falcon. The facility will mature on December 31, 2026, and requires stepped repayments of $0.5 million on December 31, 2024, $1.0 million on December 31, 2025 and $3.5 million on December 31, 2026. Borrowings under the facility will bear interest at the borrower's option at a rate equal to (a) (i) the most recent applicable Term SOFR for the longest period (for which Term SOFR is available) which is less than the applicable interest period of the loan or (ii) if no such Term SOFR is available for a period which is less than the applicable interest period, SOFR for the day which is two U.S. Government Securities Business Days, as defined in the facility, before the Quotation Day, as defined in the facility; or (b) the most recent applicable Term SOFR (as of the Quotation Day) for the shortest period (for which Term SOFR is available) which exceeds the applicable interest period of that loan, in each case plus the applicable margin. At September 30, 2025, there was $4.5 million of outstanding borrowings under the facility, of which $3.5 million and $1.0 million is recorded in long-term debt, net and current maturities of long-term debt, respectively, on the Condensed Consolidated Balance Sheets. Falcon's facility contains certain restrictive financial covenants which require Falcon to maintain certain levels of working capital, debt, and tangible net worth. Falcon was in compliance with these financial covenants as of September 30, 2025.
Supply Chain Finance Program
The Company is party to a supply chain finance program (the "Program") with a third-party financing provider to provide better working capital usage by deferring payments for certain raw materials of up to $100.0 million. Under the Program, the financing provider remits payment to the Company's suppliers for approved invoices, and the Company repays the financing provider the amount of the approved invoices, plus a financing charge, on 180-day terms. The Program is uncommitted, and the financing provider may, at its sole discretion, cancel the Program at any time. The Company may request cancellation of the Program in whole or in respect of one or more approved suppliers. Due to the extension of payment terms beyond the original due date of approved invoices, obligations under the Program are recorded outside of accounts payable, within our supply chain finance program, on our Condensed Consolidated Balance Sheets. As of September 30, 2025, there were $98.7 million obligations outstanding under the Program.
Receivables Purchase Agreement
On June 27, 2025, the Company entered into a receivable purchase agreement (the "Factoring Agreement") with a third-party financial institution (the "Factor") through which the Company may sell up to $35.0 million of certain trade receivables on a nonrecourse basis to the Factor. Transactions under the Factoring Agreement qualify for true-sale treatment in accordance with Accounting Standards Codification ("ASC") 860, Transfers and Servicing ("ASC 860"), whereby receivables sold to the Factor are recorded as a reduction of accounts receivable in the Condensed Consolidated Balance Sheets. As a part of the Factoring Agreement, we perform certain collection and administrative functions for the receivables sold.
During the nine months ended September 30, 2025, the Company received gross cash proceeds of $113.4 million related to the sale of receivables under the Factoring Agreement, remitted approximately $78.5 million of customer payments to the Factor, and incurred approximately $1.0 million of fees associated with these sales, which are recorded within selling, general and administrative expense on the Condensed Consolidated Statements of Operations. At September 30, 2025, the Company held $7.9 million of customer payments that have yet to be remitted to the Factor, which is recorded within restricted cash on the Condensed Consolidated Balance Sheets.
Green Coffee Repurchase Program
The Company is party to a master commodity purchase and sale agreement (the "Commodity Program") with a third-party financing provider whereby the Company may enter into commodities purchase and sales, including transactions in which the Company sells green coffee to the financing provider, but retains a right, or obligation, to re-purchase the green coffee at the original sales price, plus a finance charge ("Repo Transactions"). The Commodity Program is uncommitted and may be canceled by the financing provider at any time. At September 30, 2025 and December 31, 2024, the Company had a right, or obligation, to repurchase $11.8 million and $0, respectively, of green coffee from the financing provider. The liability for Repo Transactions is recorded within accrued expenses and other current liabilities on the Company's Condensed Consolidated Balance Sheets. Cash flows related to Repo Transactions are reported as financing activities in our Condensed Consolidated Statements of Cash Flows.
At-the-Market Common Stock Offering Program
We have an effective shelf registration statement on file with the SEC (the "Registration Statement") to offer and sell various securities from time to time. Under the Registration Statement, we have established an at-the-market common stock offering program (the "ATM Program") to sell shares of common stock not to exceed 5,000,000 Common Shares in the aggregate. This program is intended to provide additional financial flexibility and an alternative mechanism to access the capital markets at an efficient cost as and when we need financing, including for acquisitions. During the three and nine months ended September 30, 2025, the Company sold 1,909,676 Common Shares under the ATM Program, generating gross proceeds of $12.1 million. As of September 30, 2025, there were 3,030,324 of remaining shares authorized to be sold under ATM Program.
Current and Long-Term Liquidity
Our liquidity needs are to fund operating expenses, meet debt service obligations, and fund both current and long-term investment activities, which include capital expenditures. We have completed the majority of the capital expenditures related to the Conway Facility and have approximately $15.0 million to expenditures remaining. We believe cash from operations, and borrowings available under the Revolving Credit Facility will provide sufficient cash on-hand to fund our operating expenses, debt service, near-term investment activities and near-term growth strategies, which include, (i) extending and enhancing product offerings through innovation, (ii) expanding our customer base and (iii) continuing to drive margin expansion. However, the Company will continuously evaluate its liquidity needs, especially in light of "C" market price volatility and tariff and trading restrictions (as discussed above) and may seek to opportunistically access additional liquidity, including through either the debt or equity capital markets. If it is determined that we have insufficient liquidity to fund our operating expenses, debt service and near-term investment activities, we may delay and/or reprioritize our near-term growth strategies, which may have an adverse impact on our ability to achieve our growth objectives.
We believe that cash from operations, borrowings available under the Revolving Credit Facility and our ability to obtain future financing will provide sufficient cash on hand to fund our long-term liquidity needs and growth strategies, which include (i) expanding geographically and (ii) finding accretive acquisitions.
Redemptions of Series A Preferred Shares
After February 26, 2028, any holder of Series A Preferred Shares may require Westrock to redeem all or any whole number of such holder's Series A Preferred Shares in cash, subject to applicable law and the terms of any credit
agreement or similar arrangement pursuant to which a third-party lender provides debt financing to Westrock or its subsidiaries, at a redemption price per share equal to the greater of (a) the liquidation preference and (b) the product of (i) the number of Common Shares that would have been obtained from converting one Series A Preferred Share on the redemption notice date and (ii) the simple average of the daily volume-weighted average price per Common Share for the ten (10) trading days ending on and including the trading day immediately preceding the redemption notice date. Assuming that the liquidation preference of the Series A Preferred Shares remains $11.50 per share and all 23,510,527 Series A Preferred Shares remain outstanding after February 26, 2028, we estimate an aggregate redemption payment of at least approximately $270.4 million. If Westrock was required by the holders to redeem a significant number of Series A Preferred Shares, Westrock may not have enough cash available (including through draws on its credit facility) for other purposes such as paying dividends on the Common Shares, repurchasing Common Shares, financing acquisitions or other expansions, paying employee incentives and/or executing its business strategy. An outflow of a significant amount of cash from Westrock as a result of redemptions of the Series A Preferred Shares may cause a deterioration in the financial condition of Westrock and our ability to pay our other obligations and/or execute our business strategy. The impact of such redemptions on Westrock will depend, among other things, on the financial condition of Westrock at the time of such redemptions, including the amount of available cash on hand and ability to draw on Westrock's credit facilities or obtain other sources of financing, the business strategies and objectives of Westrock at that time and the magnitude of such redemptions. Additionally, we may reserve cash, refrain from pursuing other business objectives and/or direct cash away from other business objectives to ensure that we have sufficient available cash to satisfy holder redemptions, and this may adversely affect our business and financial condition and ability to execute on our business strategy.
Contractual and Other Obligations
Our material contractual and other obligations include the payment of principal and interest under our debt obligations and future purchase of inventory obligations. The Term Loan Facility and Delayed Draw Term Loan Facility require quarterly principal payments totaling approximately $4.2 million (1.875% of the original principal balance), increasing to approximately $5.6 million (2.5% of the original principal balance) during the final year of the agreements. We have no other material obligations to pay principal amounts of our long-term debt obligations prior to their maturity.
Future purchase obligations of $218.5 million as of September 30, 2025 consist of commitments for the purchase of inventory over the next 12 months. These obligations represent the minimum contractual obligations expected under the normal course of business. There are no material purchase obligations beyond 12 months.
We have no future obligations to repurchase inventory associated with repurchase agreements in which the Company's SS&T segment has sold inventory to a third party and from whom the Company's Beverage Solutions segment has an obligation to repurchase. At December 31, 2024, the Company had $0.6 million of such obligations.
At September 30, 2025, we had a right or obligation to repurchase $11.8 million of inventory associated with Repo Transactions, for which the liability is recorded within accrued expenses and other current liabilities on the Company's Condensed Consolidated Balance Sheets.
Capital Expenditures
We categorize our capital expenditures as (i) growth, (ii) maintenance, (iii) customer beverage equipment or (iv) other.
We define growth capital expenditures as investments in our manufacturing facilities that will contribute to revenue growth by increasing production capacity, improving production efficiencies, or related to production of new products. Maintenance capital expenditures are those necessary to keep our existing manufacturing equipment fully operational. Customer beverage equipment represents Company-owned equipment that is deployed in our customers' locations.
Capital expenditures for the nine months ended September 30, 2025 and 2024 were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Customer |
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
Beverage |
|
|
|
|
|
|
|
|
(Thousands) |
|
Growth |
|
Maintenance |
|
Equipment |
|
Other |
|
Total |
|||||
|
Nine months ended September 30, 2025 |
|
$ |
75,390 |
|
$ |
1,984 |
|
$ |
1,133 |
|
$ |
1,378 |
|
$ |
79,885 |
|
Nine months ended September 30, 2024 |
|
$ |
137,977 |
|
$ |
1,532 |
|
$ |
745 |
|
$ |
1,197 |
|
$ |
141,451 |
We have completed the majority of the capital expenditures related to the Conway Facility and have approximately $15.0 million to expenditures remaining. If circumstances warrant, we may need to take measures to conserve cash, which may include a suspension, delay, or reduction in growth and/or maintenance capital expenditures. We continually assess our capital expenditure plans in light of developments impacting our business, including the needs of our customers.
Off-Balance Sheet Arrangements
As of the date of this Quarterly Report on Form 10-Q, we do not have any off-balance sheet arrangements.
Recent Accounting Pronouncements
See Note 3, "Summary of Significant Accounting Policies," to the Condensed Consolidated Financial Statements included in Item I of Part 1 of this Quarterly Report on Form 10-Q for a detailed discussion of recent accounting pronouncements.